**Newswise — BOSTON, March 25, 2025** — Today, the not-for-profit organization [Skin Cancer Consortium Outcomes](https://www.scoutconsortium.org/) (SCOUT) launched riSCC, a data-driven clinician mobile app designed for risk stratification of cutaneous squamous cell carcinoma (cSCC) in clinical settings.
SCOUT, founded in 2018, is committed to transforming skin cancer care through education, advocacy, and research. Its new app, riSCC, is designed by Emily Ruiz, MD, MPH, Associate Professor of Dermatology, Harvard Medical School; Anokhi Jambusaria-Pahlajani MD, MSCE, Associate Professor, Division of Dermatology, Department of Internal Medicine, The University of Texas at Austin Dell Medical School; Bill Lotter, PhD, Researcher and Assistant Professor of Pathology at Dana-Farber Cancer Institute and Harvard Medical School; and Vincent Jeanselme, PhD, University of Cambridge. SCOUT’s mission is to improve skin cancer outcomes, and the riSCC app is a significant step toward transforming skin cancer prevention and treatment for patients around the world.
riSCC is built from a multinational study of over 20,000 tumors. It will be used by clinicians to analyze patient and tumor characteristics to generate an evidence-based risk score for predicting cSCC outcomes. With seamless, data-driven insights, riSCC integrates into clinical workflows, helping clinicians make informed decisions.
"We are excited to launch riSCC to help clinicians better understand the risk of outcomes and tailor surveillance and treatment plans for skin cancer patients,” said Dr. Ruiz. “Every clinician strives to answer two crucial questions: what is the likelihood of recurrence, and what is the most effective treatment plan? With riSCC, we are not just providing answers, we are equipping healthcare professionals with a tool that can transform their approach to patient care.”
“The features of riSCC empower healthcare providers to improve patient outcomes by making individualized, evidence-based treatment decisions for each patient,” said Dr. Jambusaria-Pahlajani. “Making the riSCC application available to our peers globally was a top priority.”
Clinicians can access the riSCC application at no charge by visiting the SCOUT website at [https://www.scoutconsortium.org/app-landing-page](https://www.scoutconsortium.org/app-landing-page) or by searching “riSCC” in the Google Play and Apple Stores.